Skip to search formSkip to main contentSkip to account menu

TB 402

Known as: TB-402, TB402 monoclonal antibody 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
TB-402 is a long-acting monoclonal antibody that partially inhibits factor VIII. A single administration of TB-402 was effective… 
2012
2012
Summary.  Background:  TB‐402 is a partially inhibiting antibody of factor VIII that is under development as a long‐acting… 
2011
2011
Summary.  Background: TB‐402 is a novel anticoagulant monoclonal antibody with a prolonged antithrombotic effect resulting from… 
Review
2011
Review
2011
The therapeutic armamentarium of parenteral anticoagulants available to clinicians is mainly composed by unfractionated heparin… 
2010
2010
Total VTE was lower in each of the TB-402 groups compared to the enoxaparin group: 16.7% (9.8-26.9), 23.9% (15.3-35.3), 24.1%(16…